Leslie William D, Tsang James F, Caetano Patricia A, Lix Lisa M
Faculty of Medicine, and Manitoba Centre for Health Policy, Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.
J Bone Miner Res. 2007 Mar;22(3):476-83. doi: 10.1359/jbmr.061112.
Site-discordance in BMD assessment is common and significantly affects patient categorization. Greater number of osteoporotic sites correlates with lower T scores at each index site. This largely explains the positive association between number of osteoporotic sites and fracture risk.
Site-discordance in BMD is common when used to classify patients based on a cut-off T score of -2.5. It is unclear whether fracture risk assessment is improved by considering BMD information from multiple sites. Our objective was to assess the contribution of number of osteoporotic sites to overall fracture risk.
The study population was drawn from the regionally based clinical database of the Manitoba Bone Density Program that includes all clinical DXA test results for the Province of Manitoba, Canada. Analyses were limited to 16,505 women>or=50 years of age at the time of baseline DXA of the spine (L1-L4) and hip (three sites). During follow-up (3.2+/-1.5 years), longitudinal health service records showed 765 women with at least one osteoporotic fracture code (hip, forearm, spine, or humerus).
Of 5012 women classified as osteoporotic by at least one site (T score -2.5 or lower), almost one half (2370; 47%) were abnormal at only a single site. Among the 1856 women with an osteoporotic total hip measurement, mean total hip T scores decreased as the number of additional osteoporotic sites increased (-2.58, no other osteoporotic sites; -2.69, one other site; -2.87, two other sites; -3.17, three other sites; Spearman r=-0.44, p<0.0001). Age-adjusted fracture risk from a Cox proportional hazards model increased as the number of osteoporotic sites increased (p<0.0001), but number of osteoporotic sites was no longer an independent predictor after total hip BMD was included as a covariate (p=0.19). Covariate adjustment for other sites of BMD measurement attenuated, but did not eliminate, the effect of number of osteoporotic sites.
Site-discordance is common and significantly affects patient categorization when different skeletal sites are used for diagnosis. Greater number of osteoporotic sites correlates with lower T scores at each index site. This largely explains the positive association between number of osteoporotic sites and fracture risk.
骨密度(BMD)评估中的部位不一致情况很常见,且会显著影响患者分类。骨质疏松部位数量越多,每个指标部位的T值越低。这在很大程度上解释了骨质疏松部位数量与骨折风险之间的正相关关系。
当根据-2.5的T值临界值对患者进行分类时,BMD的部位不一致情况很常见。尚不清楚考虑多个部位的BMD信息是否能改善骨折风险评估。我们的目的是评估骨质疏松部位数量对总体骨折风险的影响。
研究人群来自曼尼托巴骨密度项目基于地区的临床数据库,该数据库包含加拿大曼尼托巴省所有临床双能X线吸收法(DXA)检测结果。分析仅限于16505名在基线时进行脊柱(L1-L4)和髋部(三个部位)DXA检测时年龄≥50岁的女性。在随访期间(3.2±1.5年),纵向健康服务记录显示765名女性至少有一个骨质疏松性骨折编码(髋部、前臂、脊柱或肱骨)。
在至少一个部位被分类为骨质疏松的5012名女性中,近一半(2370名;47%)仅在单个部位异常。在1856名全髋部测量为骨质疏松的女性中,随着其他骨质疏松部位数量的增加,全髋部平均T值下降(无其他骨质疏松部位时为-2.58;有一个其他部位时为-2.69;有两个其他部位时为-2.87;有三个其他部位时为-3.17;Spearman相关系数r=-0.44,p<0.0001)。Cox比例风险模型中经年龄调整的骨折风险随着骨质疏松部位数量的增加而增加(p<0.0001),但在将全髋部BMD作为协变量纳入后,骨质疏松部位数量不再是独立预测因素(p=0.19)。对其他BMD测量部位进行协变量调整减弱了但并未消除骨质疏松部位数量的影响。
部位不一致情况很常见,且在使用不同骨骼部位进行诊断时会显著影响患者分类。骨质疏松部位数量越多,每个指标部位的T值越低。这在很大程度上解释了骨质疏松部位数量与骨折风险之间的正相关关系。